Clermont-Ferrand
Auvergne
Thea is a France-based ophthalmology company that discovers, develops and commercializes novel ophthalmic therapeutics for the treatment of eye diseases... Read more
Thea is a France-based ophthalmology company that discovers, develops and commercializes novel ophthalmic therapeutics for the treatment of eye diseases... Read more
President
Jean-Frederic Chibret
News
Jul 07, 2025
centralcharts
Press Release: Laboratoires Thea : LENZ Therapeutics and Laboratoires Tha Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada
Oct 03, 2024
Pharamceutical Technology
Laboratoires Thea: Novaliq and Laboratoires Tha announce EC approval for dry eye disease therapy
Feb 10, 2024
Eyewire News
Laboratoires Thea: Novaliq and Laboratoires Tha Announce Partnership and EU Approval for Vevizye
Feb 02, 2024
Medthority
Laboratoires Thea: Kiora Pharmaceuticals has entered into an agreement with Tha Open Innovation SAS concerning the KIO-301 molecular photoswitch product
Dec 08, 2023
StreetInsider
Press Release: Laboratoires Thea : ProQR Therapeutics Announces Transaction Completed for Tha to Acquire Sepofarsen and Ultevursen Ophthalmic Assets
Oct 12, 2023
FinSMEs
Laboratoires Thea: Tilak Healthcare Raises 10M in Funding
Aug 01, 2023
BioSpace
Laboratoires Thea: ProQR Therapeutics and Laboratoires Tha Announce Agreement for Tha to Acquire ProQR's Sepofarsen and Ultevursen Ophthalmic Assets
Dec 15, 2022
Business Wire
Press Release: Laboratoires Thea : Thea Pharma Announces FDA Approval of IYUZEH for the Reduction of Elevated Intraocular Pressure (IOP) in Patients with Open-angle Glaucoma or Ocular Hypertension
Jun 14, 2022
BioSpace
Laboratoires Thea: Vyluma and Laboratoires Tha Enter into Licensing Agreement for the Registration and Commercialization of NVK002 in Canada, Mexico, and Select South American Countries
May 19, 2022
VisionMonday
Laboratoires Thea: Labtician Tha Announces Successful Completion of Joint Venture
Laboratoires Thea Competitors
1
2
3
4
5
6
7
8
9
10